This is a 12 week treatment study to evaluate the efficacy of a new medication compared to placebo in lowering pain intensity in patients with PHN.

Major Inclusion/Exclusion Criteria:

• Ages 18-80
• Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)